0001209191-20-008370.txt : 20200211 0001209191-20-008370.hdr.sgml : 20200211 20200211170244 ACCESSION NUMBER: 0001209191-20-008370 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200210 FILED AS OF DATE: 20200211 DATE AS OF CHANGE: 20200211 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Arbet-Engels Christophe CENTRAL INDEX KEY: 0001802615 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35890 FILM NUMBER: 20597928 MAIL ADDRESS: STREET 1: C/O MILLENDO THERAPEUTICS, INC. STREET 2: 110 MILLER AVENUE, SUITE 100 CITY: ANN ARBOR STATE: MI ZIP: 48104 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Millendo Therapeutics, Inc. CENTRAL INDEX KEY: 0001544227 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 451472564 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 110 MILLER AVENUE, SUITE 100 CITY: ANN ARBOR STATE: MI ZIP: 48104 BUSINESS PHONE: 734-845-9000 MAIL ADDRESS: STREET 1: 110 MILLER AVENUE, SUITE 100 CITY: ANN ARBOR STATE: MI ZIP: 48104 FORMER COMPANY: FORMER CONFORMED NAME: OvaScience, Inc. DATE OF NAME CHANGE: 20120308 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-02-10 0 0001544227 Millendo Therapeutics, Inc. MLND 0001802615 Arbet-Engels Christophe C/O MILLENDO THERAPEUTICS, INC. 110 MILLER AVENUE, SUITE 100 ANN ARBOR MI 48104 0 1 0 0 Chief Medical Officer Employee Stock Option (right to buy) 6.90 2020-02-10 4 A 0 140000 0.00 A 2030-02-09 Common Stock 140000 140000 D Twenty-five percent (25%) of the shares subject to this option shall vest on February 10, 2021, and one thirty-sixth (1/36th) of the remaining shares subject to this option shall vest each month thereafter, subject to the recipient continuing to provide service through that date. /s/ Jason Minio, Attorney-in-Fact 2020-02-11